CNTA Centessa Pharmaceuticals plc

CNTA Centessa Pharmaceuticals plc

Healthcare · Biotechnology

No longer tracked since 2026-08-14 — left the market.

Market read

Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)

Last report May 14

Reported the quarter ending 2026-03-31: revenue $0, diluted EPS $-0.52, net income $-79M (SEC filing).

full note →

CNTA research tape

10 dated scans, research, and events, newest first — the full record.

earnings CNTA earnings — 2026-08-11 (no report: company acquired) scan Monster Scan scan Monster Scan scan Monster Scan scan Monster Scan
Types
Aug 11 Catalyst CNTA earnings — 2026-08-11 (no report: company acquired)
CNTA
Jun 25 Scan Monster Scan
005930.KS5991.T6779.TAAAALAAONAAUCABCL +4 more
Jun 20 Scan Monster Scan
005930.KS298040.KS5991.T6779.TAAMIAAOIAAONABSI +4 more
Jun 16 Scan Monster Scan
005930.KS6779.TAAOIAEHRAIXA.DEALABALRIB.PAAMKR +4 more
May 29 Scan Monster Scan
005930.KS6779.TAAAAOIACLSACLXAEHRAGX +4 more
May 14 Catalyst CNTA earnings
CNTA
Apr 28 Scan Monster Scan
AAOIADEAAEHRAEISAFRMAGXALMAMD +4 more
Apr 26 Scan Monster Scan
AAAAOIAAUCACHCACLSACLXADEAAEHR +4 more
Mar 31 Scan Monster Scan
AAAAOIACLXADEAAEISAEMAGIAGX +4 more
Mar 26 Scan Monster Scan
AAOIACLXADEAAEISAEMAGIAGXAHG +4 more